Bobak Azamian

CEO

Board Member

Chairman

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

TARS

Current role

CEO, Board Member, Chairman

2022-12-02–present

2 calls Latest call 2024-05-08

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Tarsus Pharmaceuticals, Inc. (TARS)	M.D., Ph.D. President, Chief Executive Officer and Board Chairman	$726,333	—	$2,648,284	$2,651,487	$555,700	$36,175	$6,617,979
2024	Tarsus Pharmaceuticals, Inc. (TARS)	M.D., Ph.D. President, Chief Executive Officer and Board Chairman	$673,400	—	$3,370,153	$3,267,692	$532,800	$52,147	$7,896,192
2023	Tarsus Pharmaceuticals, Inc. (TARS)	M.D., Ph.D. President, Chief Executive Officer and Board Chairman	$619,500	—	$1,029,364	$1,017,968	$450,300	$13,200	$3,130,332
2022	Tarsus Pharmaceuticals, Inc. (TARS)	M.D., Ph.D. President, Chief Executive Officer and Board Chairman	$590,000	—	$876,822	$2,077,378	$324,500	$47,580	$3,916,280
2021	Tarsus Pharmaceuticals, Inc. (TARS)	M.D., Ph.D. President, Chief Executive Officer and Board Chairman	$550,000	—	—	$6,029,589	$269,500	$21,634	$6,870,723
2020	Tarsus Pharmaceuticals, Inc. (TARS)	M.D., Ph.D. President, Chief Executive Officer and Director	$437,000	$211,484	—	$1,847,092	—	$14,820	$2,510,396
2019	Tarsus Pharmaceuticals, Inc. (TARS)	M.D. Ph.D. President, Chief Executive Officer and Director	$300,000	$116,137	—	—	—	—	$416,137

Earnings-call appearances and filed executive appointments or departures, newest first.